Do Patient Preferences Align With Value Frameworks? A Discrete-Choice Experiment of Patients With Breast Cancer

被引:3
|
作者
Hollin, Ilene L. [2 ]
Gonzalez, Juan Marcos [1 ]
Buelt, Lisabeth [3 ]
Ciarametaro, Michael [3 ]
Dubois, Robert W. [3 ]
机构
[1] Duke Univ, Sch Med, 2400 Pratt St, Durham, NC 27705 USA
[2] Temple Univ, Coll Publ Hlth, Philadelphia, PA USA
[3] Natl Pharmaceut Council, Washington, DC USA
关键词
breast cancer; discrete-choice experiment; value frameworks;
D O I
10.1177/2381468320928012
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose. Assess patient preferences for aspects of breast cancer treatments to evaluate and inform the usual assumptions in scoring rubrics for value frameworks. Methods. A discrete-choice experiment (DCE) was designed and implemented to collect quantitative evidence on preferences from 100 adult female patients with a self-reported physician diagnosis of stage 3 or stage 4 breast cancer. Respondents were asked to evaluate some of the treatment aspects currently considered in value frameworks. Respondents' choices were analyzed using logit-based regression models that produced preference weights for each treatment aspect considered. Aggregate- and individual-level preferences were used to assess the relative importance of treatment aspects and their variability across respondents. Results. As expected, better clinical outcomes were associated with higher preference weights. While life extensions with treatment were considered to be most important, respondents assigned great value to out-of-pocket cost of treatment, treatment route of administration, and the availability of reliable tests to help gauge treatment efficacy. Two respondent classes were identified in the sample. Differences in class-specific preferences were primarily associated with route of administration, out-of-pocket treatment cost, and the availability of a test to gauge treatment efficacy. Only patient cancer stage was found to be correlated with class assignment (P = 0.035). Given the distribution of individual-level preference estimates, preference for survival benefits are unlikely to be adequately described with two sets of preference weights. Conclusions. Although value frameworks are an important step in the systematic evaluation of medications in the context of a complex treatment landscape, the frameworks are still largely driven by expert judgment. Our results illustrate issues with this approach as patient preferences can be heterogeneous and different from the scoring weights currently provided by the frameworks.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] PREFERENCES FOR CHEMOTHERAPY SIDE EFFECTS IN SAUDI BREAST CANCER PATIENTS: A DISCRETE-CHOICE EXPERIMENT
    Alaqeel, S.
    Alnaim, L.
    Abuzaid, R.
    AlSudairi, R.
    Hiligsmann, M.
    VALUE IN HEALTH, 2019, 22 : S528 - S529
  • [2] PATIENT PREFERENCES FOR DIALYSIS MODALITIES: A DISCRETE-CHOICE EXPERIMENT
    Walker, R.
    Morton, R.
    Palmer, S.
    Marshall, M.
    Tong, A.
    Howard, K.
    NEPHROLOGY, 2017, 22 : 48 - 48
  • [3] Discrete-choice experiment to measure patient preferences for the surgical management of colorectal cancer
    Salkeld, G
    Solomon, M
    Butow, P
    Short, L
    BRITISH JOURNAL OF SURGERY, 2005, 92 (06) : 742 - 747
  • [4] Line of Therapy and Patient Preferences Treating Lung Cancer: A Discrete-Choice Experiment
    Bridges, J.
    Roy, U. Basu
    Janssen, E.
    Ferris, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S378 - S379
  • [5] A discrete-choice experiment to elicit patient preferences for the surgical management of oesophagogastic cancer
    Thrumurthy, Sri G.
    Mughal, Muntzer M.
    BRITISH JOURNAL OF SURGERY, 2010, 97 : 49 - 49
  • [6] Patient and caregiver preferences for haemophilia treatments: A discrete-choice experiment
    Garcia, Viridiana Cano
    Mansfield, Carol
    Pierce, Anna
    Leach, Colton
    Smith, Jane Cavanaugh
    Afonso, Marion
    HAEMOPHILIA, 2024, 30 (02) : 375 - 387
  • [7] Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment
    Mansfield, Carol
    Gebben, David J.
    Sutphin, Jessie
    Tepper, Stewart J.
    Schwedt, Todd J.
    Sapra, Sandhya
    Shah, Neel
    HEADACHE, 2019, 59 (05): : 715 - 726
  • [8] Patient preferences for DCIS treatment strategies: A discrete-choice experiment
    Campbell, Brittany
    Yang, Jui-Chen
    Gonzalez, Juan
    Reed, Shelby
    Havrilesky, Laura
    Johnson, F. Reed
    Hwang, Shelley
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 268 - 269
  • [9] Line of therapy and patient preferences regarding lung cancer treatment: a discrete-choice experiment
    Janse, Sarah
    Janssen, Ellen
    Huwig, Tanya
    Basu Roy, Upal
    Ferris, Andrea
    Presley, Carolyn J.
    Bridges, John F. P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (04) : 643 - 653
  • [10] Patients’ preferences for osteoporosis drug treatment: a discrete-choice experiment
    Mickaël Hiligsmann
    Benedict G Dellaert
    Carmen D Dirksen
    Trudy van der Weijden
    Stefan Goemaere
    Jean-Yves Reginster
    Verity Watson
    Annelies Boonen
    Arthritis Research & Therapy, 16